The upregulation of REG3A correlates with early stage HCC and β-catenin mutation, and it is reported to be a downstream target of β-catenin mutation in the Wnt pathway in vitro (Yuan et al., 2005; Cavard et al., 2006). This evidence concerns the gene REG3A and hepatocellular carcinoma.